<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for OXGN</title>
    <link />
    <description>Headlines for OXIGENE, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>OXiGENE Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1407181-oxigene-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 06 May 2013 19:01:08 GMT</pubDate>
    </item>
    <item>
      <title>OXiGENE's Oncology Drugs Have Run Their Course</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1388991-oxigene-s-oncology-drugs-have-run-their-course.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 10:33:40 GMT</pubDate>
    </item>
    <item>
      <title>OXiGENE Closes Enrollment of ZYBRESTAT Phase 2 Ovarian Cancer Trial</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3526576/oxigene-closes-enrollment-of-zybrestat-phase-2-ovarian-cancer-trial.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 24 Apr 2013 16:11:47 GMT</pubDate>
    </item>
    <item>
      <title>OXiGENE Announces $5M Private Placement</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3489327/oxigene-announces-5m-private-placement.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 11 Apr 2013 08:33:43 GMT</pubDate>
    </item>
    <item>
      <title>Morning Market Movers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3486209/morning-market-movers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 10 Apr 2013 10:05:45 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3479006/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 08 Apr 2013 11:37:02 GMT</pubDate>
    </item>
    <item>
      <title>Solving The R&amp;D Investment Dilemma With Project Funding: Mark Kessel</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1297051-solving-the-r-d-investment-dilemma-with-project-funding-mark-kessel.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 24 Mar 2013 04:30:20 GMT</pubDate>
    </item>
    <item>
      <title>OXiGENE Announces Patent for Benzosuberenes</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3433741/oxigene-announces-patent-for-benzosuberenes.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Mar 2013 16:08:26 GMT</pubDate>
    </item>
    <item>
      <title>OXiGENE Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1268551-oxigene-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 12 Mar 2013 19:01:09 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks Under $5 Making Big Moves</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-stocks-under-5-making-big-moves.html-3.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 05 Feb 2013 14:19:00 GMT</pubDate>
    </item>
    <item>
      <title>Risk Vs. Reward: 2 Biotech Stocks I'm Considering In The Wake Of Recent Developments</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1025731-risk-vs-reward-2-biotech-stocks-i-m-considering-in-the-wake-of-recent-developments.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 23 Nov 2012 12:55:17 GMT</pubDate>
    </item>
    <item>
      <title>OXiGENE's CEO Discusses Q3 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/996931-oxigene-s-ceo-discusses-q3-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 09 Nov 2012 19:19:03 GMT</pubDate>
    </item>
    <item>
      <title>4 Pharmaceutical Companies Moving On News</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/783661-4-pharmaceutical-companies-moving-on-news.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 06 Aug 2012 11:05:43 GMT</pubDate>
    </item>
    <item>
      <title>ASCO Stocks To Consider This Week</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/621551-asco-stocks-to-consider-this-week.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 29 May 2012 01:59:44 GMT</pubDate>
    </item>
    <item>
      <title>Inhibitex Investors: Why Shares Popped 115%</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2011/11/05/inhibitex-investors-why-shares-popped-115/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 05 Nov 2011 16:51:31 GMT</pubDate>
    </item>
    <item>
      <title>You Should Have Seen These Biotech Failures Coming</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2011/11/04/you-should-have-seen-these-biotech-failures-coming/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 04 Nov 2011 19:28:56 GMT</pubDate>
    </item>
    <item>
      <title>Cancer Data Deluge Ripples Through Biotech Stocks</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20110519-000487&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Thu, 19 May 2011 12:18:59 GMT</pubDate>
    </item>
    <item>
      <title>A Simplified ASCO 2011 List for Biotech Investor Research</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/268682-a-simplified-asco-2011-list-for-biotech-investor-research.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 09 May 2011 05:56:34 GMT</pubDate>
    </item>
    <item>
      <title>ASCO 2011: Opportunities for Biotech Investor Success and Failure</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/266950-asco-2011-opportunities-for-biotech-investor-success-and-failure.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 02 May 2011 09:14:12 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Mixed at Mid-Session as President Sends Budget Proposal to Congress</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2011-02/stocks-mixed-at-midsession-as-president-sends-budget-proposal-to-congress.aspx.aspx?storyid=57602&amp;source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 14 Feb 2011 12:30:58 GMT</pubDate>
    </item>
  </channel>
</rss>
